Most of my patients do not describe this treatment as willpower. They describe it as quiet. The food noise turns down, the plate gets ahead of them, and a meal they have cooked for twenty years suddenly ends at the halfway mark.

That experience has a biology, and understanding it will make every later chapter easier.

What tends to change

GLP-1-based medications amplify a signal your body already uses to regulate eating. In studies, four changes show up most often: appetite falls, so hunger arrives later and softer; food reward shifts, so cravings and the pull of rich food lose some grip; fullness arrives earlier in the meal; and the practical result is that meal capacity shrinks — most people simply eat less without deciding to.

Appetite falls, food reward shifts, and fullness arrives earlier, converging on one practical result: meal capacity shrinks and most people simply eat less without deciding to. Effects vary between people and medications and can shift over time. — Four changes, one practical result — with wide person-to-person variation.

In a small crossover trial, people on semaglutide reduced their daily food intake by roughly a quarter without being asked to diet. A sixty-week trial found something worth knowing: the reduced intake persisted across the year even as the subjective feelings — the obvious "I'm not hungry" — faded for some people. Your eating can stay changed after the novelty wears off. And a six-week tirzepatide study found smaller meals and fewer cravings, but no change in deliberate restraint. The medication changes signals; it does not install discipline, and you do not need it to.

The slower stomach, with honest caveats

These medications can also slow how quickly the stomach empties, which contributes to that early, insistent fullness. But the effect varies widely from person to person, tends to fade for many people as treatment continues, and is not the same as food sitting in your stomach indefinitely. If a rich or heavy meal sits badly in the early months, that is a tolerance signal we will work with in Chapter 5 — not proof that something is wrong.

One more honest caveat: none of this is uniform. Appetite effects differ between people, differ between medications, and can shift around dose changes and over time. Your experience is allowed to differ from your friend's.

This book stays on the eating side of that line. Nausea, vomiting, constipation, and the serious-but-rare risks have their own book — GLP-1 Side Effects and Safety — and if symptoms rather than food choices are your main question, start there.

The takeaway. Expect appetite, cravings, fullness, and meal capacity to change — unevenly, and on their own schedule. The chapters ahead are about making a smaller intake do more, starting with the plate itself.